Sargent Investment Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,670
Closed -$13.5K 237
2025
Q1
$13.5K Sell
16,670
-7,615
-31% -$6.15K ﹤0.01% 232
2024
Q4
$35.7K Sell
24,285
-18,845
-44% -$27.7K 0.01% 232
2024
Q3
$44.9K Hold
43,130
0.01% 210
2024
Q2
$74.6K Sell
43,130
-5,570
-11% -$9.64K 0.02% 212
2024
Q1
$116K Buy
48,700
+22,640
+87% +$54.1K 0.03% 192
2023
Q4
$86.8K Buy
26,060
+6,368
+32% +$21.2K 0.02% 204
2023
Q3
$73.6K Hold
19,692
0.02% 197
2023
Q2
$84.1K Buy
+19,692
New +$84.1K 0.02% 191
2023
Q1
Sell
-11,200
Closed -$88.7K 198
2022
Q4
$88.7K Sell
11,200
-3,970
-26% -$31.4K 0.03% 186
2022
Q3
$148K Sell
15,170
-6,355
-30% -$62K 0.05% 173
2022
Q2
$156K Sell
21,525
-5,105
-19% -$37K 0.05% 171
2022
Q1
$344K Sell
26,630
-13,104
-33% -$169K 0.09% 137
2021
Q4
$634K Sell
39,734
-6,806
-15% -$109K 0.14% 107
2021
Q3
$748K Sell
46,540
-51,195
-52% -$823K 0.18% 95
2021
Q2
$1.35M Sell
97,735
-6,748
-6% -$93.3K 0.32% 56
2021
Q1
$1.53M Buy
104,483
+6,739
+7% +$98.4K 0.4% 49
2020
Q4
$1.7M Sell
97,744
-8,092
-8% -$141K 0.54% 39
2020
Q3
$1.94M Buy
105,836
+14,656
+16% +$269K 0.71% 31
2020
Q2
$1.66M Buy
91,180
+9,505
+12% +$173K 0.63% 35
2020
Q1
$1.33M Buy
81,675
+17,420
+27% +$283K 0.61% 38
2019
Q4
$1.16M Buy
64,255
+22,720
+55% +$409K 0.42% 49
2019
Q3
$841K Buy
41,535
+24,920
+150% +$505K 0.38% 64
2019
Q2
$367K Buy
+16,615
New +$367K 0.17% 99